Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioHybrid Solutions is a preclinical-stage biotechnology company specializing in the development of protein-polymer conjugates to enhance the therapeutic potential of biologics. The company utilizes its proprietary NanoArmor technology, an atom transfer radical polymerization (ATRP) platform, to precisely wrap individual protein molecules in a protective polymer shell. This technology is designed to improve the stability, pharmacokinetics, and efficacy of enzymes and other proteins while reducing immunogenicity. BioHybrid Solutions is currently focusing its internal pipeline on enzyme replacement therapies for lysosomal storage disorders and has established partnerships to apply its platform to various other therapeutic and industrial applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio-Hybrid D.